SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis
NASDAQ:SMLR - Nasdaq - US81684M1045 - Common Stock - Currency: USD
Taking everything into account, SMLR scores 5 out of 10 in our fundamental rating. SMLR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. SMLR has an excellent profitability rating, but there are some minor concerns on its financial health. SMLR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
SMLR had a positive operating cash flow in the past year.
In the past 5 years SMLR has always been profitable.
Each year in the past 5 years SMLR had a positive operating cash flow.
1.2 Ratios
SMLR has a Return On Assets of -10.18%. This is in the better half of the industry: SMLR outperforms 61.50% of its industry peers.
The Return On Equity of SMLR (-18.48%) is better than 61.50% of its industry peers.
The Return On Invested Capital of SMLR (4.18%) is better than 75.94% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SMLR is significantly above the industry average of 7.89%.
The 3 year average ROIC (20.14%) for SMLR is well above the current ROIC(4.18%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.18% | ||
| ROE | -18.48% | ||
| ROIC | 4.18% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
1.3 Margins
In the last couple of years the Profit Margin of SMLR has grown nicely.
SMLR's Operating Margin of 25.61% is amongst the best of the industry. SMLR outperforms 95.19% of its industry peers.
In the last couple of years the Operating Margin of SMLR has grown nicely.
Looking at the Gross Margin, with a value of 90.96%, SMLR belongs to the top of the industry, outperforming 98.93% of the companies in the same industry.
SMLR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.61% | ||
| PM (TTM) | N/A | ||
| GM | 90.96% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SMLR is creating value.
SMLR has more shares outstanding than it did 1 year ago.
SMLR has more shares outstanding than it did 5 years ago.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SMLR has an Altman-Z score of 3.27. This indicates that SMLR is financially healthy and has little risk of bankruptcy at the moment.
SMLR has a Altman-Z score of 3.27. This is in the better half of the industry: SMLR outperforms 70.59% of its industry peers.
The Debt to FCF ratio of SMLR is 5.75, which is a neutral value as it means it would take SMLR, 5.75 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.75, SMLR is doing good in the industry, outperforming 79.68% of the companies in the same industry.
SMLR has a Debt/Equity ratio of 0.59. This is a neutral value indicating SMLR is somewhat dependend on debt financing.
SMLR has a worse Debt to Equity ratio (0.59) than 66.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 5.75 | ||
| Altman-Z | 3.27 |
ROIC/WACC0.46
WACC9.07%
2.3 Liquidity
A Current Ratio of 0.52 indicates that SMLR may have some problems paying its short term obligations.
The Current ratio of SMLR (0.52) is worse than 93.58% of its industry peers.
A Quick Ratio of 0.51 indicates that SMLR may have some problems paying its short term obligations.
With a Quick ratio value of 0.51, SMLR is not doing good in the industry: 93.05% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.51 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 38.28% over the past year.
The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.29%.
The Revenue has been growing by 11.43% on average over the past years. This is quite good.
EPS 1Y (TTM)38.28%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%-197.44%
Revenue 1Y (TTM)-25.29%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.41%
3.2 Future
The Earnings Per Share is expected to decrease by -42.94% on average over the next years. This is quite bad
SMLR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -23.99% yearly.
EPS Next Y-162.85%
EPS Next 2Y-42.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-41.41%
Revenue Next 2Y-23.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.31, the valuation of SMLR can be described as very reasonable.
94.12% of the companies in the same industry are more expensive than SMLR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SMLR to the average of the S&P500 Index (27.41), we can say SMLR is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for SMLR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.31 | ||
| Fwd PE | N/A |
4.2 Price Multiples
SMLR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 65.24% of the companies in the same industry.
SMLR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 79.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.45 | ||
| EV/EBITDA | 54.4 |
4.3 Compensation for Growth
SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as SMLR's earnings are expected to decrease with -42.94% in the coming years.
PEG (NY)N/A
PEG (5Y)0.47
EPS Next 2Y-42.94%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for SMLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:SMLR (7/14/2025, 3:33:08 PM)
45.35
-0.18 (-0.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners50.43%
Inst Owner Change0%
Ins Owners4.89%
Ins Owner Change0.32%
Market Cap625.38M
Analysts82.86
Price Target72.42 (59.69%)
Short Float %27.73%
Short Ratio2.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-294.32%
EPS NY rev (3m)-294.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-42.03%
Revenue NY rev (3m)-42.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.31 | ||
| Fwd PE | N/A | ||
| P/S | 12.7 | ||
| P/FCF | 37.45 | ||
| P/OCF | 37.05 | ||
| P/B | 3.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 54.4 |
EPS(TTM)4.01
EY8.84%
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)1.21
FCFY2.67%
OCF(TTM)1.22
OCFY2.7%
SpS3.57
BVpS11.72
TBVpS-7.38
PEG (NY)N/A
PEG (5Y)0.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.18% | ||
| ROE | -18.48% | ||
| ROCE | 4.89% | ||
| ROIC | 4.18% | ||
| ROICexc | 4.34% | ||
| ROICexgc | N/A | ||
| OM | 25.61% | ||
| PM (TTM) | N/A | ||
| GM | 90.96% | ||
| FCFM | 33.93% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexcg growth 3Y32.01%
ROICexcg growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 5.75 | ||
| Debt/EBITDA | 7.32 | ||
| Cap/Depr | 34.42% | ||
| Cap/Sales | 0.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 128.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.51 | ||
| Altman-Z | 3.27 |
F-Score3
WACC9.07%
ROIC/WACC0.46
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)38.28%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%-197.44%
EPS Next Y-162.85%
EPS Next 2Y-42.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.29%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.41%
Revenue Next Year-41.41%
Revenue Next 2Y-23.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-45.14%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year8.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.95%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y0.36%
OCF growth 3Y14.98%
OCF growth 5Y13.91%